What is Exagen Inc.'s stock issuance proceeds?

Exagen Inc. (XGN) reported stock issuance proceeds of $295K in Q1 2026.

How has Exagen Inc.'s stock issuance proceeds changed year-over-year?

Exagen Inc.'s stock issuance proceeds increased by 49.0% year-over-year, from $198K to $295K.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Exagen Inc. XGN Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Quest DiagnosticsDGX

$65M+124%

Avalo TherapeuticsAVTX

$2.18M—

CareDxCDNA

$109K-96.4%

Bio-Rad LaboratoriesBIO

$3.4M-20.9%

RevvityRVTY

$5.44M+107%

Idexx LaboratoriesIDXX

$18.16M+152%

Other financials

Income statement

See full

Revenue$17.3M+11.7%

Gross profit$10.2M+11.9%

Operating income-$3.4M-1.5%

Net income-$4.0M-5.7%

EPS (diluted)-$0.17+15.0%

Balance sheet

See full

Cash & equivalents$21.7M+90.6%

Total debt$27.1M+15.8%

Total equity$14.4M+125%

Total assets$52.0M+28.9%

Cash flow

See full

Operating cash flow-$10.4M+2.4%

CapEx$228.0K+102%

Free cash flow-$10.6M+1.3%

Valuation

See full

Market cap$112.34M-26.5%

Enterprise value$117.78M-20.3%

P/S1.6×-1.0×

Profitability

See full

Gross margin58.3%-1.0pp

Operating margin-20.6%-2.9pp

Net margin-29.5%+2.5pp

FCF margin-27.5%—

Returns & leverage

See full

Return on equity-193.6%+355pp

Debt / equity1.9×-1.8×

Current ratio3.5×+1.1×

Where this comes from

Reported directly by Exagen Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockPlans.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Exagen Inc.'s stock issuance proceeds?: Exagen Inc. (XGN) reported stock issuance proceeds of $295K in Q1 2026.
How has Exagen Inc.'s stock issuance proceeds changed year-over-year?: Exagen Inc.'s stock issuance proceeds increased by 49.0% year-over-year, from $198K to $295K.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.